Congestive Heart Failure by
the Numbers1

More than 8 million Americans are estimated to have CHF by 2030, resulting in

$53Billion*

in direct CHF medical costs

$70Billion

indirect CHF costs

$160Billion*

total cardiovascular care direct costs 

$3,594

Per patient

incremental adjusted annual medical costs for CHF

$32,955

Per patient

total annual medical costs for CHF

Approximately

6.7M Americans

over the age of 20 have heart failure and the revalence is expected to rise to

8.5M by 2030

*2010 dollars
1. J Card Fail. 2023; 29 P1412-1451

Technology Overview: Nasal Diuretic

Loop diuretics are one of the top medications used to manage fluid overload caused by congestive heart failure (CHF), liver, and kidney disease.

Medications delivered nasally avoid the absorption-limiting effects of first-pass metabolism and are transported via the nasal capillary network to systemic circulation.

Our nasal diuretic provides a self-administered outpatient option for patients suffering from congestion.

rsq-mobile-graphic